Head and neck squamous cell carcinomas (HNSCCs) arise in the mucosal linings of the
upper aerodigestive tract and are heterogeneous in nature. Risk factors for HNSCCs are …

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer
worldwide and is frequently impervious to curative treatment efforts. Similar to other cancers …

Head and neck cancer (HNC) is a common malignant tumor, but traditional therapeutic
methods have unsatisfactory curative effects and many complications occur. Hence, there is …

Immune checkpoint inhibitor (ICI) therapy has revolutionized the treatment of many cancer
types, including head and neck cancers (HNC). When checkpoint and partner proteins bind …

Precision medicine is an approach to disease prevention and treatment that takes into
account genetic variability and environmental and lifestyle influences that are unique to …

The prognostic role of epidermal growth factor receptor (EGFR) in head and neck squamous
cell carcinoma (HNSCC) remains controversial. The goal of this study was to summarize …

Despite improvements in functional outcomes attributable to advances in radiotherapy,
chemotherapy, surgical techniques, and imaging techniques, survival in head and neck …

The rise in human papillomavirus (HPV)-associated head and neck squamous cell
carcinoma (HNSCC) has elicited significant interest in the role of high-risk HPV in …

Nimotuzumab is a blocking monoclonal antibody against epidermal growth factor receptor
(EGFR). However, little is known about the safety and preliminary efficacy of nimotuzumab …

The roles of the epidermal growth factor receptor (EGFR) signaling pathway in various
cancers including breast, bladder, brain, colorectal, esophageal, gastric, head and neck …